Startup · $45m raised

Prospection

Sydney, NSW

Investors

Every investor coverage indicates participated in a round Prospection raised.

Investor	Rounds	Invested
Ellerston Capital	Series B	$30,000,000
Ellerston Ventures	Series B	-
Horizons Ventures	Series B	-
Main Sequence Ventures	Series B	-

On a portfolio page

Investors whose own portfolio pages list Prospection, even though we haven't found any coverage of the round yet.

Investor	Listed on
Glitch Capital	its portfolio page ↗

What Prospection bought

Companies Prospection acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company	Kind	Announced	Price	Sources
Prospection is not recorded as having acquired anything.

People

Name	Role	Sources
Dr Peter Cronin	Head of Data & Partnerships	prospection.com
Eric Chung	CEO	prospection.com
Ricky Chen	CTO	prospection.com

Coverage

Stories naming Prospection. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

11 deals

Aussie startups raised $471 million in September — the strongest funding month since March

SmartCompany summarises Cut Through Venture's report finding Australian startups closed 71 deals worth $471 million in September 2022, the strongest month since March, led by hardware, while revisiting large September 2021 raises.

SmartCompany 6 Oct 2022 Airwallex Alex Bank Canva Delegate Connect Immutable Mable Morse Micro Prospection Scalapay Siteminder Who Gives A Crap

Also Startup Daily·Startup Daily

2 deals

Prospection Secures $45 million to Accelerate Growth

Australian health-data analytics firm Prospection has closed a $45 million Series B, cornerstoned by Ellerston JAADE with Main Sequence and Horizons Ventures participating; its $10 million Series A dates to February 2020.

prospection.com 14 Sep 2021 Prospection Cicada Innovations Ellerston Ventures Horizons Ventures Main Sequence Ventures Bill Bartee David Leslie Eric Chung Dr Peter Cronin Ricky Chen

Series B $45m

Ellerston Capital backs Prospection in $45m raise

Prospection's $45 million Series B has Ellerston Capital's JAADE fund as cornerstone investor with $30 million, while existing shareholders Main Sequence Ventures and Horizons Ventures also backed the healthcare data company.

AFR Technology 13 Sep 2021 Prospection CSIRO Ellerston Capital Horizons Ventures Main Sequence Ventures

Also prospection.com·pharmadispatch.com·SmartCompany

Something wrong? Tell us